Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Brenntag SEXSWX:BNR +0.11%85 EV-to-EBIT is 14.91 as of Aug. 01, 2026, which is 34% above its 10-year median of 11.14. GuruFocus rates XSWX:BNR with a GF Score™ of 85/100 and a GF Value™ of CHF53.12. The stock has 12 warning signs investors should review. Among 1,241 Chemicals companies, Brenntag SE ranks better than 56.24% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Brenntag SE's Enterprise Value for the quarter that ended in Mar. 2026 was CHF7,381 Mil.
Brenntag SE's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF544 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brenntag SE EV-to-EBIT Related Terms
Brenntag SE EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Brenntag SE's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Brenntag SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Brenntag SE EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Brenntag SE's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Brenntag SE's EV-to-EBIT falls into.
Brenntag SE's current Enterprise Value is CHF8,110 Mil.
Brenntag SE's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF544 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brenntag SE (XSWX:BNR) has a EV-to-EBIT of 14.91 as of Aug. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Brenntag SE and its competitors. This is 34% above median its historical median of 11.14. Over the past decade, Brenntag SE's EV-to-EBIT has ranged from 6.04 to 20.31. According to the industry distribution chart, Brenntag SE ranks #543 out of 1241 companies in the Chemicals industry, placing it in the top 43.8%.
Is Brenntag SE's EV-to-EBIT too high?
Brenntag SE's current EV-to-EBIT of 14.91 is 34% above median its 10-year median of 11.14. Over the past 10 years, this metric has ranged from a low of 6.04 to a high of 20.31. The Chemicals industry median EV-to-EBIT is 16.86. Brenntag SE's value of 14.91 is 11.6% below this industry median. Based on the distribution chart, Brenntag SE ranks #543 out of 1241 companies in the Chemicals industry, which is above the industry midpoint. Overall, Brenntag SE has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Brenntag SE's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Brenntag SE ranks #543 out of 1241 companies for EV-to-EBIT. This puts Brenntag SE in the upper half of its industry. The industry median EV-to-EBIT is 16.86. Brenntag SE's value of 14.91 is 11.6% below this benchmark. Historically, Brenntag SE's own EV-to-EBIT has ranged from 6.04 to 20.31 over the past decade. While the company's 10-year median is 11.14 vs. the industry median of 16.86, Brenntag SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.86, based on 1,241 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Brenntag SE's current EV-to-EBIT of 14.91 is 11.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Brenntag SE and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brenntag SE's current EV-to-EBIT is 14.91, which is 34% above median its own 10-year median of 11.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brenntag SE stock overvalued right now?
Brenntag SE (XSWX:BNR) has a current EV-to-EBIT of 14.91. The stock's GF Value™ is CHF53.12, compared to a current price of CHF56.02 — trading 5.5% above its estimated fair value. The current EV-to-EBIT is 14.91, which is 34% above median its 10-year median of 11.14 and 11.6% below the Chemicals industry median of 16.86. Brenntag SE's overall GF Score™ is 85/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Brenntag SE (XSWX:BNR), the current EV-to-EBIT is 14.91 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Brenntag SE (XSWX:BNR) Overvalued in 2026?
Based on GuruFocus' analysis, Brenntag SE stock appears to be overvalued.
The current stock price of CHF56.02 is trading 5.5% above its estimated GF Value™ of CHF53.12.
Key valuation signals for XSWX:BNR:
EV-to-EBIT: 14.91 (34% above median its 10-year median of 11.14)
GF Value™: CHF53.12 vs. price of CHF56.02 (5.5% above fair value)
Industry Position: 11.6% below the Chemicals median (#543 of 1241)
No single metric tells the full story. See the XSWX:BNR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Brenntag SE manufactures, distributes, and sells chemicals and chemical-based products. It operates in two reportable segments life science, material science and Specialties Other. Life science chemicals are used to produce cosmetics, food, animal nutrition, and pharmaceuticals. The material science chemicals are used to produce soaps and detergents, coatings, and paints as well as the extraction of oil and gas. The company organizes itself into four segments based on geography EMEA, North America, Latin America, and APAC.
85GF Score
Get the complete analysis for XSWX:BNR
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BNR has been successfully added to your 
